NuVasive (NUVA) received regulatory Shonin approval for ReLine™ posterior fixation technology in Japan. Launch will commence later in 2016 and continue into 2017.
This approval supports the pending Japan launch of the Integrated Global Alignment or iGA platform for spinal alignment.
NUVA is planning for >30% growth in its Japanese market for 2016. The company cites Japan as the world’s second largest spine market and NUVA’s largest market ex-U.S. NUVA first entered the Japanese market in 2013, with its Precept® posterior fixation system.
NuVasive (NUVA) received regulatory Shonin approval for ReLine™ posterior fixation technology in Japan. Launch will commence later in 2016 and continue into 2017.
This approval supports the pending Japan launch of the Integrated Global Alignment or iGA platform for spinal alignment.
NuVasive (NUVA) received regulatory Shonin approval for ReLine™ posterior fixation technology in Japan. Launch will commence later in 2016 and continue into 2017.
This approval supports the pending Japan launch of the Integrated Global Alignment or iGA platform for spinal alignment.
NUVA is planning for >30% growth in its Japanese market for 2016. The company cites Japan as the world’s second largest spine market and NUVA’s largest market ex-U.S. NUVA first entered the Japanese market in 2013, with its Precept® posterior fixation system.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
